Epigenetically Modified Endothelial Progenitor Cells in Heart Failure

Alexander E Berezin

Published Date: 2016-06-08
DOI10.21767/2472-1158.100021
Visit for more related articles at

Abstract

Heart failure is a global health and medical problem that increases burden of cardiovascular (CV) disease. By now, there is not completely recognition regarding the reasons of various phenotypes of HF development, distinguish in CV risk, clinical outcomes and prognosis. It has suggested that epigenetic modification of several cell components of endogenous repair system might determine phenotypical response of the failing heart and contributes to nature evolution of HF. Moreover, epigenetically modified endothelial progenitor cells playing a central role in the tissue reparation and angiogenesis may link aging, genetic predisposition, co-morbidities, traditional CV risk factor and HF progression. The editorial comment devotes the consideration of the role of epigenetic in manifestation of progenitor endothelial cell dysfunction and perspectives to restore its reparative ability in HF individuals.

open access journals, open access scientific research publisher, open access publisher
Select your language of interest to view the total content in your interested language

Viewing options

Flyer image

Share This Article